当期純利益、偶発損失引当金、関係会社株式売却益（IFRS）他1件
- 【期間】
| 年度 | 当期純利益 | 偶発損失引当金 | 関係会社株式売却益（IFRS） | 研究開発費 |
|---|
| 2008/03 | 36.6億 | | - | | - | | - | |
| 2009/03 | 13.7億 | -62.6% | - | | - | | - | |
| 2010/03 | 32.4億 | +136.9% | - | | - | | - | |
| 2011/03 | 26.8億 | -17.1% | - | | - | | - | |
| 2012/03 | 33.2億 | +23.6% | - | | - | | - | |
| 2013/03 | 69億 | +107.9% | - | | - | | 11.3億 | |
| 2014/03 | - | | - | | - | | 17.6億 | +55.7% |
| 2015/03 | - | | - | | - | | 16.9億 | -4.4% |
| 2015/12 | - | | - | | - | | 15.4億 | -8.7% |
| 2016/12 | - | | - | | - | | 15.2億 | -1.4% |
| 2017/12 | - | | - | | - | | 13.1億 | -14% |
| 2018/12 | - | | - | | - | | 13.7億 | +5.1% |
| 2019/12 | - | | - | | 24.1億 | | 13億 | -5% |
| 2020/12 | - | | - | | - | | 9.17億 | -29.6% |
| 2021/12 | - | | - | | - | | 13.4億 | +45.8% |
| 2022/12 | - | | 176百万 | | 369億 | 大幅増 | 8.89億 | -33.5% |
| 2023/12 | - | | 176百万 | ±0% | - | | 17.9億 | +100.9% |
